DK29086D0 - Diagnosemetode til paavisning af sygdomme omfattende en arthritis-komponent - Google Patents

Diagnosemetode til paavisning af sygdomme omfattende en arthritis-komponent

Info

Publication number
DK29086D0
DK29086D0 DK29086A DK29086A DK29086D0 DK 29086 D0 DK29086 D0 DK 29086D0 DK 29086 A DK29086 A DK 29086A DK 29086 A DK29086 A DK 29086A DK 29086 D0 DK29086 D0 DK 29086D0
Authority
DK
Denmark
Prior art keywords
component
arthritis
diseases including
diagnosis method
determining diseases
Prior art date
Application number
DK29086A
Other languages
English (en)
Other versions
DK29086A (da
DK164417C (da
DK164417B (da
Inventor
Raymond A Dwek
Thomas W Rademacher
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK29086D0 publication Critical patent/DK29086D0/da
Publication of DK29086A publication Critical patent/DK29086A/da
Publication of DK164417B publication Critical patent/DK164417B/da
Application granted granted Critical
Publication of DK164417C publication Critical patent/DK164417C/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/827Lectins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Control Of El Displays (AREA)
DK029086A 1985-01-22 1986-01-21 Diagnosemetode til paavisning af rheumatoid arthritis eller osteoarthritis DK164417C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69307585 1985-01-22
US06/693,075 US4659659A (en) 1985-01-22 1985-01-22 Diagnostic method for diseases having an arthritic component

Publications (4)

Publication Number Publication Date
DK29086D0 true DK29086D0 (da) 1986-01-21
DK29086A DK29086A (da) 1986-07-23
DK164417B DK164417B (da) 1992-06-22
DK164417C DK164417C (da) 1992-11-16

Family

ID=24783210

Family Applications (1)

Application Number Title Priority Date Filing Date
DK029086A DK164417C (da) 1985-01-22 1986-01-21 Diagnosemetode til paavisning af rheumatoid arthritis eller osteoarthritis

Country Status (14)

Country Link
US (1) US4659659A (da)
EP (1) EP0189388B1 (da)
JP (1) JP2515289B2 (da)
AT (1) ATE78518T1 (da)
AU (1) AU586662B2 (da)
CA (1) CA1272670A (da)
DE (1) DE3686061T2 (da)
DK (1) DK164417C (da)
FI (1) FI88341C (da)
GR (1) GR860167B (da)
IE (1) IE58727B1 (da)
IL (1) IL77666A (da)
NO (1) NO166302C (da)
ZA (1) ZA86442B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component
GB8618443D0 (en) * 1986-07-29 1986-09-03 Univ London Monoclonal antibodies
GB8714270D0 (en) * 1987-06-18 1987-07-22 Williams G R Analysis of carbohydrates
US4791067A (en) * 1987-06-25 1988-12-13 Fisher Scientific Co. Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5100778A (en) * 1989-10-03 1992-03-31 Monsanto Company Oligosaccharide sequencing
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
JP3537535B2 (ja) * 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンg結合糖鎖構造に基づく臨床検査方法
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases
IL129835A (en) * 1999-05-06 2008-03-20 Ofer Markman Polysaccharide sequencing and structure determination
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
US20040132131A1 (en) * 2001-11-05 2004-07-08 Ofer Markman Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same
EP1583968B1 (en) * 2003-01-14 2015-04-22 VIB, vzw A serum marker for measuring liver fibrosis
CA2527916A1 (en) * 2003-03-14 2004-09-30 Aaron B. Kantor Biological markers for diagnosing rheumatoid arthritis
WO2005015200A1 (ja) * 2003-08-11 2005-02-17 Shionogi Co., Ltd. 血清を用いた簡易疾患診断およびテーラーメイド治療
US20050186645A1 (en) * 2003-12-18 2005-08-25 Yehudit Amor Method for analyzing a glycomolecule
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
US7892752B2 (en) * 2005-04-26 2011-02-22 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
US8039208B2 (en) * 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
AU2006257904B2 (en) * 2005-06-10 2012-04-19 Mannatech, Inc. Rapid saccharide biomarker assay
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
SI2068918T1 (sl) 2006-09-26 2012-09-28 Infectious Disease Res Inst Si - ep sestavek za cepljenje, ki vsebuje sintetiäśna pomagala
US20100266558A1 (en) * 2007-12-18 2010-10-21 Dov Zipori Method and assay for glycosylation pattern detection related to cell state of stem cells
PT2437753T (pt) 2009-06-05 2016-11-23 Infectious Disease Res Inst Adjuvantes lipídicos de glucopiranosilo sintéticos e composições de vacina contendo os mesmos
MX350795B (es) 2011-04-08 2017-09-19 Inmune Design Corp Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
ES2729967T3 (es) 2012-02-07 2019-11-07 Infectious Disease Res Inst Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
PT2850431T (pt) 2012-05-16 2018-07-23 Immune Design Corp Vacinas para hsv-2
JP6426706B2 (ja) 2013-04-18 2018-11-21 イミューン デザイン コーポレイション がん処置で使用するためのgla単剤療法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
JP6741580B2 (ja) 2013-12-31 2020-08-19 インフェクシャス ディズィーズ リサーチ インスティチュート 単一バイアルのワクチン製剤
MX2021010105A (es) 2016-06-01 2022-06-16 Infectious Disease Res Inst Particulas de nanoalumbre que contienen un agente de dimensionamiento.
CA3141577A1 (en) 2019-05-25 2020-12-03 Infectious Disease Research Institute Composition and method for spray drying an adjuvant vaccine emulsion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088875A (en) * 1959-10-27 1963-05-07 Hyland Lab Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
US4213764A (en) * 1978-08-09 1980-07-22 Akzona Incorporated Method for determining immunochemical substances
US4282002A (en) * 1979-09-06 1981-08-04 Akzona Incorporated Sensitized sheep stroma immunoassay for rheumatoid factor
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
US4457865A (en) * 1982-03-08 1984-07-03 Research Corporation Sialic acid specific slug lectin
US4420461A (en) * 1982-05-26 1983-12-13 Ortho Diagnostic Systems Inc. Agglutination-inhibition test kit for detecting immune complexes
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component

Also Published As

Publication number Publication date
FI88341B (fi) 1993-01-15
GR860167B (en) 1986-05-22
US4659659A (en) 1987-04-21
EP0189388A2 (en) 1986-07-30
DK29086A (da) 1986-07-23
DE3686061T2 (de) 1993-03-11
CA1272670C (en) 1990-08-14
NO166302C (no) 1991-06-26
NO860191L (no) 1986-07-23
DE3686061D1 (de) 1992-08-27
IE860176L (en) 1986-07-22
FI860284A (fi) 1986-07-23
IE58727B1 (en) 1993-11-03
NO166302B (no) 1991-03-18
FI860284A0 (fi) 1986-01-21
ZA86442B (en) 1986-10-29
AU586662B2 (en) 1989-07-20
JPS61170657A (ja) 1986-08-01
CA1272670A (en) 1990-08-14
EP0189388A3 (en) 1988-11-30
ATE78518T1 (de) 1992-08-15
AU5253886A (en) 1986-07-31
DK164417C (da) 1992-11-16
IL77666A (en) 1990-12-23
FI88341C (fi) 1993-04-26
EP0189388B1 (en) 1992-07-22
DK164417B (da) 1992-06-22
JP2515289B2 (ja) 1996-07-10

Similar Documents

Publication Publication Date Title
DK29086D0 (da) Diagnosemetode til paavisning af sygdomme omfattende en arthritis-komponent
EP0644412A3 (de) Verfahren zur Analyse klinisch relevanter Flüssigkeiten und Suspensionen.
BR9507690A (pt) Detecção de reticulócitos
FR2592170B1 (fr) Procede et dispositif pour delivrer une quantite predeterminee de plasma a partir d'un echantillon de sang en vue d'analyses.
DE69832628D1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
EP0419502A4 (en) Method of detecting bacteria in urine
DE69636749D1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
DE3783966T2 (de) Reagens zur pruefung von periodentalen erkrankungen.
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
ES8202639A1 (es) Procedimiento para la deteccion y determinacion de monomero de fibrina en liquidos biologicos
FI922666A0 (fi) Diagnostiskt foerfarande.
EP0217768A3 (en) Method and compositions for heparin assays
FI892536A0 (fi) Menetelmä mykoplasmabakteerien laskemiseksi ja toteamiseksi
NO902158L (no) Proteinholdig forbindelse for diagnostisk anvendelse.
DK0674718T3 (da) Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi
GR900100011A (en) New diagnostic method
EP0788595A4 (en) METHOD FOR TESTING IMMUNOCOMPETENCY
DE69023500D1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.
FR2574090B1 (fr) Ensemble pour determiner la resistance intrinseque d'une famille de bacteries et methode de determination de cette resistance intrinseque
UA28862A (uk) Спосіб визначення необхідності тестування на вілінфекцію
IT1228295B (it) Composizioni barriera atte a separare il siero dalla frazione corpuscolare coagulata del sangue.

Legal Events

Date Code Title Description
PUP Patent expired